Ambey Laboratories Limited (NSE:AMBEY)

Market Cap	785.82M -36.0%
Revenue (ttm)	1.33B +2.3%
Net Income	44.37M -5.8%
EPS	1.78
Shares Out	24.95M
PE Ratio	17.71
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,000
Average Volume	92,100
Open	31.50
Previous Close	31.50
Day's Range	29.95 - 31.50
52-Week Range	16.20 - 48.30
Beta	n/a
RSI	58.84
Earnings Date	May 20, 2026

About Ambey Laboratories

Ambey Laboratories Limited manufactures and distributes agro chemicals and home hygiene products in India. The company offers 2,4-D acid tech, sodium salt, amine salt, ethyl hexyl ester tech, and ethyl ester tech; and chlorpyriphos, thiamethoxam, pretilachlor, metribuzin, hexaconazole, clodinofob tech, and lambda cyhalothrine tech. It also exports its products. Ambey Laboratories Limited was incorporated in 1985 and is based in Gurugram, India.

• Industry: Agricultural Chemicals
• Founded: 1985
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AMBEY

Financial Performance

In fiscal year 2025, Ambey Laboratories's revenue was 1.33 billion, an increase of 9.00% compared to the previous year's 1.22 billion. Earnings were 47.83 million, a decrease of -38.06%.